<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01461226</url>
  </required_header>
  <id_info>
    <org_study_id>EC 11/11/100</org_study_id>
    <nct_id>NCT01461226</nct_id>
  </id_info>
  <brief_title>Endothelial Dysfunction in Obese Children</brief_title>
  <acronym>EDOC</acronym>
  <official_title>Adolescent Obesity: What Determines Vascular Endothelial Dysfunction And Is The Process Reversible?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zeepreventorium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to objectify the effect of diet and exercise on early markers of
      atherosclerosis in obese children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The favorable responses of combined treatment strategies, consisting of exercise training and
      proper diet change, for childhood and adolescent obesity on vascular health are poorly
      understood. The overall objective of this research project is to investigate the underlying
      pathophysiological mechanisms that mediate these beneficial effects.

      Particularly, the following aims are set forth:

        1. To establish the effect of a combined lifestyle intervention, i.e. an individualized
           exercise training and caloric restriction program, on vascular function (primary
           endpoint) and structure in a substantial population of obese adolescents.

        2. To characterize causal pathways between obesity and endothelial dysfunction with focus
           on classical risk factors, oxidative and inflammatory stress, metabolic adaptations,
           bone marrow derived progenitor cells, and blood microparticles.

      This research knowledge will be instrumental for risk stratification and clinical management
      aimed to improve endothelial function by limiting damage and reinforcing regenerative
      mechanisms in obese adolescents.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Reactive Hyperemia Index at 5 and 10 months</measure>
    <time_frame>Baseline - 5 months - 10 months</time_frame>
    <description>Reactive Hyperemia Index as assessed using endoPAT (R) is used as a marker for endothelial function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in exercise capacity at 5 and 10 months</measure>
    <time_frame>Baseline - 5 months - 10 months</time_frame>
    <description>Exercise capacity will be assessed using bicycle ergometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Body Mass Index and body composition at 5 and 10 months</measure>
    <time_frame>Baseline - 5 months - 10 months</time_frame>
    <description>Weight and Length will be assessed to calculate Body Mass Index(BMI) and BMI-Z-score. Dual-X-Ray Absorptiometry will be used to estimate body composition</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obesity</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Exercise training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>Individualized and progressively increased supervised aerobic exercise program on a daily base (3-4hours per day, hypocaloric diet and psychological guidance</description>
    <arm_group_label>Exercise training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Nutritional assessment and dietary advice by general practitioner, promotion of sports activities</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Children with severe obesity

          -  Younger than 16 yrs: BMI ≥97th sex and age specific BMI-percentile

          -  Older than 16 yrs: BMI ≥35 kg/m²

        Exclusion Criteria:

          -  Acute or chronic inflammatory process, use of non-steroidal anti- inflammatory drugs
             or immunosuppressive drugs. (including inhalation corticosteroids).

          -  Structural heart disease or other cardiac diseases.

          -  Active malignant hematological disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viviane M Conraads, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Viviane M Conraads, M.D., PhD</last_name>
    <phone>38215672</phone>
    <phone_ext>0032</phone_ext>
    <email>viviane.conraads@uza.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luc Bruyndonckx, M.D.</last_name>
    <phone>38215222</phone>
    <phone_ext>0032</phone_ext>
    <email>luc.bruyndonckx@uza.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zeepreventorium</name>
      <address>
        <city>De Haan</city>
        <zip>8420</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hilde Franckx, M.D.</last_name>
      <phone>59233911</phone>
      <phone_ext>0032</phone_ext>
      <email>hilde.franckx@zeepreventorium.be</email>
    </contact>
    <investigator>
      <last_name>Hilde Franckx, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viviane M Conraads, M.D.,PhD</last_name>
      <phone>38214672</phone>
      <phone_ext>0032</phone_ext>
      <email>viviane.conraads@uza.be</email>
    </contact>
    <investigator>
      <last_name>Luc Bruyndonckx, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dienst Pediatrie, Universitair Ziekenhuis Antwerpen</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Ramet, M.D, PhD</last_name>
      <phone>38214115</phone>
      <phone_ext>0032</phone_ext>
      <email>jose.ramet@uza.be</email>
    </contact>
    <investigator>
      <last_name>José Ramet, M.D., PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc Bruyndonckx, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2011</study_first_submitted>
  <study_first_submitted_qc>October 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2011</study_first_posted>
  <last_update_submitted>October 28, 2011</last_update_submitted>
  <last_update_submitted_qc>October 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Antwerp</investigator_affiliation>
    <investigator_full_name>Conraads Viviane</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>overweight</keyword>
  <keyword>cardiovascular risk factors</keyword>
  <keyword>exercise training</keyword>
  <keyword>endothelial function</keyword>
  <keyword>endothelium</keyword>
  <keyword>endothelial progenitor cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

